Cwestiwn ysgrifenedig WQ90465
- Gofynnwyd gan
- Andrew RT DaviesCeidwadwyr
- I'w ateb gan
- Minister for Health and Social Services
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 11 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What plans does the Welsh Government have to make the Arexvy vaccine readily available in Wales to treat respiratory syncytial virus?
Ateb
Atebwyd gan Minister for Health and Social Services
Arexvy is an approved vaccine to protect against Respiratory Syncytial Virus (RSV) that may be used to protect older adults. There are also other licensed products which could be used to protect against RSV.
The Joint Committee on Vaccination and Immunisation has recommended establishing an RSV vaccination programme, if vaccines can be procured at a cost-effective price. Such a programme could provide protection for both older adults and infants.
The Welsh Government and NHS Wales are now working with the other UK Nations to explore options for standing up an RSV vaccination programme.